BCRX 7.57 (+2.44%)
US09058V1035BiotechnologyBiotechnology

BioCryst Pharmaceuticals (BCRX) Stock Highlights

7.57 | +2.44%
2024-12-21 03:52:57
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocrysts research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Statistics

Range Today
7.25 7.6
Volume Today 5.07M
Range 1 Year
4.03 8.88
Volume 1 Year 715.37M
Range 3 Year
4.03 19.99
Volume 3 Year 2.37B
Range 10 Year
1.38 19.99
Volume 10 Year 6.79B

Highlights

Market Capitalization 1.61B (small)
Floating Shares 192.65M
Current Price 7.57
Price To Earnings -12.18
Price To Revenue 5.15
Earnings Per Share -0.62
Payout Ratio 0%

Performance

Latest +2.44%
1 Month +5.73%
3 Months -7.12%
6 Months +26.59%
1 Year +26.8%
3 Years -41.04%
5 Years +135.83%
10 Years -34%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.